公開報告
公開研究報告
由運營明確公開發布到本站的多智能體研究報告。每份都有分析日期與投資組合經理最終評級。僅供研究參考,不構成投資建議,也不執行交易。
來自投資組合經理的五檔最終評級,不是交易員的中間動作。
- 持有
Costco Wholesale Corporation
COSTNASDAQHold current position; use $935–$938 as tactical probe zone and $925 as stop/reduce level.
分析日期2026-08-24
分析語言英語
報告數量2 份
閱讀報告 - 持有
Arcturus Therapeutics Holdings, Inc.
ARCTNASDAQHold current position pending definitive LUNAR-CF clinical data and regulatory guidance at the November 11, 2026 earnings call.
分析日期2026-08-24
分析語言英語
報告數量1 份
閱讀報告 - 持有
OmniAb, Inc.
OABINASDAQHold current position with strict trailing stop-loss at $4.40 to balance participation in momentum with capital protection.
分析日期2026-08-24
分析語言英語
報告數量1 份
閱讀報告 - 持有
Moderna, Inc.
MRNANASDAQHold MRNA with adjusted risk controls: reduce position size by 30%, move stop-loss to $130, and add a protective put.
分析日期2026-08-22
分析語言英語
報告數量1 份
閱讀報告 - 持有
Aveanna Healthcare Holdings Inc
AVAHNASDAQHold current position in AVAH while awaiting Q3 earnings for concrete evidence of debt reduction progress.
分析日期2026-08-21
分析語言英語
報告數量1 份
閱讀報告 - 持有
AtaiBeckley Inc.
ATAINASDAQHold current position with disciplined risk management: maintain exposure, set stop at $7.10, and take partial profits at $7.45–$7.50.
分析日期2026-08-21
分析語言英語
報告數量1 份
閱讀報告 - 減持
AtriCure, Inc.
ATRCNASDAQReduce exposure by 30% now; hold remainder with $43.00 stop-loss and wait for pullback confirmation before re-entry.
分析日期2026-08-21
分析語言英語
報告數量1 份
閱讀報告 - 賣出
ARC Group Acquisition I Corp Class A
ARCLNASDAQSell immediately: ARCL is structurally overvalued with no credible path to close its merger before liquidation.
分析日期2026-08-21
分析語言英語
報告數量1 份
閱讀報告 - 買入
StoneBridge Acquisition II Corporation Class A
APACNASDAQPortfolio Manager’s Final Trading Decision: APAC (StoneBridge Acquisition II Corporation Class A)
分析日期2026-08-21
分析語言英語
報告數量1 份
閱讀報告 - 持有
Amylyx Pharmaceuticals, Inc.
AMLXNASDAQPortfolio Manager’s Final Trading Decision: AMLX
分析日期2026-08-21
分析語言英語
報告數量1 份
閱讀報告 - 持有
Apogee Acquisition Corp Class A
AACPNASDAQHold current position; await definitive merger announcement or decisive technical breakout above $10.0633 with volume > 100K.
分析日期2026-08-21
分析語言英語
報告數量1 份
閱讀報告 - 持有
Lam Research Corporation
LRCXNASDAQHold current position in LRCX pending resolution of key catalysts: Q4 earnings (Oct 21), confirmed close above $337.77 on high volume, and stabilization of insider selling.
分析日期2026-08-19
分析語言英語
報告數量1 份
閱讀報告 - 持有
Applied Materials, Inc.
AMATNASDAQHold current position; await decisive technical confirmation above $520.26 or below $463.49 before adjusting exposure.
分析日期2026-08-19
分析語言英語
報告數量1 份
閱讀報告 - 持有
Cisco Systems, Inc.
CSCONASDAQHold current position while awaiting resolution of the core margin–growth tension.
分析日期2026-08-19
分析語言英語
報告數量1 份
閱讀報告 - 持有
Walmart Inc.
WMTNASDAQHold current position; use Q2 earnings on August 20 as the decisive catalyst for Overweight or Underweight action.
分析日期2026-08-19
分析語言英語
報告數量2 份
閱讀報告 - 持有
SELLAS Life Sciences Group, Inc.
SLSNASDAQHold current position in SLS; await definitive GPS Phase 3 readout or technical breakout/breakdown for adjustment.
分析日期2026-08-17
分析語言英語
報告數量1 份
閱讀報告 - 持有
Climb Bio, Inc.
CLYMNASDAQHold current position with disciplined price-based contingencies and catalyst-driven reassessment.
分析日期2026-08-17
分析語言英語
報告數量1 份
閱讀報告 - 持有
New Era Energy & Digital, Inc.
NUAINASDAQHold current position; add only upon verified PPA or construction commencement with milestones.
分析日期2026-08-17
分析語言英語
報告數量1 份
閱讀報告